Mel's Blog

The FDA has reversed an earlier decision involving Regenxbio’s experimental gene therapy for Hunter syndrome, a rare genetic disorder that primarily affects children. The agency is now allowing the treatment to move forward in the regulatory process, giving the company another opportunity to pursue approval after concerns had previously cast doubt on its path.

The therapy, known as navsunli, is designed to deliver a functioning copy of a gene that patients with Hunter syndrome lack. Supporters argue that gene therapy could address the underlying cause of the disease rather than simply managing symptoms, potentially offering long-term benefits for patients with limited treatment options.

The reversal highlights the challenges regulators face when evaluating treatments for rare diseases. Decisions often involve balancing potential risks against the urgent needs of patients and families, especially when clinical data is promising but still evolving. The FDA's latest move gives renewed hope to those following the therapy's progress.

Observation:

Microsoft is facing criticism after reports that it threatened a security researcher with a potential criminal investigation during a dispute over vulnerability disclosures. The controversy centers on researcher Mike Walters, who said he was contacted by Microsoft's legal team after reporting issues involving exposed internal data and security weaknesses.

According to the reports, Walters had been investigating publicly accessible Microsoft systems and documenting what he found. After sharing details with the company, the situation reportedly escalated beyond a normal vulnerability disclosure process, with Microsoft warning that some of his actions could be viewed as unauthorized access.

The incident has sparked debate within the cybersecurity community, where coordinated disclosure programs depend on researchers being able to investigate and report flaws without fear of legal retaliation. Critics argue that aggressive legal responses can discourage independent security research, while companies often maintain that they must protect systems and user data when investigating how information was accessed.

My Feedback:

Microsoft is testing new Windows 11 customization options for people in the Windows Insider Experimental channel.

The update lets users pick between small and large Start menu sizes, with the choice staying the same across displays. Microsoft is also adding toggles for Start menu sections like Pinned, Recommended, and All.

Other changes include separate controls for file recommendations, an option to hide your name and profile picture in Start, and more taskbar placement choices on the top, bottom, left, or right side of the screen.

A proposal from within Canada’s startup and venture capital space is offering an alternative approach to how investment funds are structured and supported. Jesse Wiebe, connected to the Canadian Venture Capital and Private Equity Association, has put forward a plan aimed at improving how capital flows to growing companies.

The idea focuses on adjusting current models to better support long-term investment and make funding more accessible for Canadian startups. It comes at a time when there’s ongoing concern about keeping innovation and high-growth companies competitive within Canada rather than losing them to other markets.

The proposal is part of a broader conversation about how to strengthen the country’s venture ecosystem, especially as global competition for capital and talent continues to increase.

My Feedback: It’s interesting how often these conversations come back to structure rather than just the amount of money—like the system itself might be the bigger bottleneck.